The boys, aged 16 to 17, have been charged with a series of violence offences after witnesses say a machete and screwdriver were used during yet another frightening knife attack. Police say rival ...

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails An asylum seeker who was seen dancing and laughing ...

【10月24日周五，美国制药巨头礼来宣布收购生物科技公司Adverum，纳入其实验性产品Ixo - vec】礼来官网公告显示，其将收购Adverum，以每股3.56美元的价格收购所有流通普通股，还附带每股8.91美元不可转让的“或有价值权”，若Adverum达到两个里程碑，每股价格最高 ...

A cowardly and cold-blooded killer who stalked a young woman as she made her way home before stabbing her to death on a train station platform has shown no remorse for his actions. Evil Deng Chol ...

Oct 24 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Friday it would acquire gene therapy developer Adverum Biotechnologies (ADVM.O), opens new tab in a deal valued at up to $261.7 million, ...

Killer had only arrived in UK on small boat three months before horror A MIGRANT has been found guilty of murdering an asylum hotel worker after he stalked her to a deserted station then stabbed her ...

A Channel boat migrant has been found guilty of the unprovoked murder of a British mother who worked at the asylum hotel where he was living. Deng Chol Majek, who claims to be 19 but has no ...

Just as Adverum Biotechnologies' cash reserves were running dry, Eli Lilly has swooped in to buy the biotech and its phase 3-stage eye disease gene therapy. The prize for Lilly is ixo-vec, an ...

A killer asylum seeker who slaughtered a mum on a deserted train platform in a horrific screwdriver murder has been convicted by jurors. Sudanese national Deng Chol Majek stabbed Rhiannon Skye Whyte ...

Eli Lilly will acquire Adverum Biotechnologies for $3.56 per share, with potential additional payments through a CVR based on Ixo-vec's success. The acquisition is expected to close in Q4 2025, ...

Adverum's lead program, Ixo-vec, is a Phase 3 gene therapy designed to treat vision loss associated with wet age-related macular degeneration with a single intravitreal dose Acquisition aligns Lilly's ...

Adverum Biotechnologies, a gene therapy developer, has agreed to sell all its outstanding shares to Eli Lilly for an upfront amount that is less than the company’s most recent closing stock price.